For an executive summary of this white paper, click here.
CMA has long recognized that tobacco use is a costly habit that often leads to illness and poor health; in 1963, CMA was the first among state medical societies to create policy to inform people about the harmful effects of cigarette smoking. Effective policy solutions that prevent and reduce tobacco use and the negative health impacts of these products should be guided by the current literature and research that indicates these interventions are necessary – namely, that there is a preponderance of evidence that highlights emerging issues and which can be used to help guide tobacco control efforts.
This report presents the evidence and research on the impact of flavored and mentholated tobacco products on public health, particularly among priority populations. Priority populations are groups that have higher rates of tobacco use than the general population, experience greater secondhand smoke exposure at work and at home, are disproportionately targeted by the tobacco industry, and have higher rates of tobacco-related disease compared to the general population.
Specifically, this report addresses the evidence linking flavored and mentholated tobacco products with initiation of and sustained tobacco use by youth and other priority populations, and the resulting negative health effects.